Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A global action agenda for turning the tide on fatty liver disease
Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 502-523
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 31
Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1761-1778
Closed Access | Times Cited: 30
Opportunities and challenges following approval of resmetirom for MASH liver disease
Jeffrey V. Lazarus, Dana Ivancovsky‐Wajcman, Henry E. Mark, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3402-3405
Closed Access | Times Cited: 24
Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa
Zobair M. Younossi, Pegah Golabi, James M. Paik, et al.
Liver International (2024) Vol. 44, Iss. 4, pp. 1061-1070
Closed Access | Times Cited: 22
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 21
Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Markos Kalligeros, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 4
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 2
Interleukin-13 (IL-13)—A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis
Elke Roeb
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12884-12884
Open Access | Times Cited: 23
Envisioning how to advance the MASH field
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 13
Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States—Author's Reply
Pojsakorn Danpanichkul, Donghee Kim, Chun‐Wei Pan, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
G. Issa, Ying Shang, Rickard Strandberg, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 1
Dissecting Acute Drug‐Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver‐On‐A‐Chip Model
Hanyang Liu, Yin Guo, Marlene Kohlhepp, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 8
Food inequity and insecurity and MASLD: burden, challenges, and interventions
Shira Zelber‐Sagi, Patrizia Carrieri, Juan M. Pericàs, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 10, pp. 668-686
Closed Access | Times Cited: 8
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease
Dana Ivancovsky‐Wajcman, Christopher J. Byrne, John Dillon, et al.
Hepatology (2024)
Open Access | Times Cited: 6
Metabolic dysfunction‐associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study
Juan Vaz, Peter Jepsen, Ulf Strömberg, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 1, pp. 40-51
Open Access | Times Cited: 5
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Consolato Sergi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8462-8462
Open Access | Times Cited: 4
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease
Jacob J. Gries, Jeffrey V. Lazarus, Paul Brennan, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 1, pp. 82-94
Closed Access | Times Cited: 4
Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials
Samuel Dinerman, Yan Shu
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Encuesta sobre los conocimientos de la enfermedad hepática metabólica (EHMet) entre los médicos de Atención Primaria en España
Carlos Martínez, Sonia Fernández Jorde, Ana Belén García-Garrido, et al.
Medicina de Familia SEMERGEN (2025) Vol. 51, Iss. 5, pp. 102448-102448
Closed Access
From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management
Paula Iruzubieta, Carolina Jiménez-González, Joaquín Cabezas, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Hallazgos por imagen de las enfermedades hepáticas por depósito
A.C. Igual Rouilleault, S. Jiménez, Jonathan D. Moreno, et al.
Radiología (2025)
Closed Access
A call to action to address the steatotic liver disease public health threat in Barcelona
Jeffrey V. Lazarus, J Emilio Miralles-Sanchez, Leire Agirre-Garrido, et al.
The Lancet Regional Health - Europe (2025) Vol. 52, pp. 101272-101272
Closed Access
Preventive Hepatology and the Healthy Life, Healthy Liver Initiative: A Roadmap to Liver Wellness
Ajeet Singh Bhadoria, Samiran Nundy, Pankaj Singh
Journal of Medical Evidence (2025) Vol. 6, Iss. 1, pp. 1-3
Open Access
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
Virginia Solitano, Çharles N. Bernstein, Iris Dotan, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Assessing Clinician Engagement with a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic
Arpan Mohanty, Kirsten Austad, Nicholas A. Bosch, et al.
Endocrine Practice (2025)
Closed Access
Page 1 - Next Page

Scroll to top